Literature DB >> 9491503

Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens.

S Di Fabio1, D Medaglini, C M Rush, F Corrias, G L Panzini, M Pace, P Verani, G Pozzi, F Titti.   

Abstract

Cynomolgus monkeys (Macaca fascicularis) were immunized by intravaginal administration of live recombinant Streptococcus gordonii. The vaccine strains of S. gordonii expressed the V3 domain of the gpl20 of human immunodeficiency virus type 1 (HIV-1), and the E7 protein of human papillomavirus type 16 (HPV 16). Multiple inocula of recombinant bacteria were used, since S. gordonii could persist for no longer than 3 days in the monkey vagina. Vaginal immunization was found to induce a local and systemic immune response specific for the heterologous antigen expressed by the bacteria. This antigen-specific immune response consisted of vaginal IgA, serum IgG, and a T-cell proliferative response measured on PBMCs. Vaginal IgG and serum IgA were not detected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491503     DOI: 10.1016/s0264-410x(97)80002-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Authors:  Donata Medaglini; Annalisa Ciabattini; Anna Maria Cuppone; Caterina Costa; Susanna Ricci; Massimo Costalonga; Gianni Pozzi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

Review 3.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

4.  Sustained delivery of commensal bacteria from pod-intravaginal rings.

Authors:  Manjula Gunawardana; Madeline Mullen; Jennifer Yoo; Paul Webster; John A Moss; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

5.  Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains.

Authors:  A Sharma; K Honma; R T Evans; D E Hruby; R J Genco
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.

Authors:  Annalisa Ciabattini; Anna Maria Cuppone; Rita Pulimeno; Francesco Iannelli; Gianni Pozzi; Donata Medaglini
Journal:  Clin Vaccine Immunol       Date:  2006-09

7.  The oral commensal, Streptococcus gordonii, synergizes with Tat protein to induce HIV-1 promoter activation in monocytes/macrophages.

Authors:  Octavio A González; Jeffrey L Ebersole; Chifu B Huang
Journal:  Cell Immunol       Date:  2011-03-15       Impact factor: 4.868

8.  Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii.

Authors:  S Corinti; D Medaglini; C Prezzi; A Cavani; G Pozzi; G Girolomoni
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.

Authors:  Annalisa Ciabattini; Elena Pettini; Peter Andersen; Gianni Pozzi; Donata Medaglini
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.